Drug-induced liver injury—types and phenotypes

Acetaminophen‐induced acute liver failure

Larson, A. M., Polson, J., Fontana, R. J., Davern, T. J., Lalani, E., Hynan, L. S., REISCH, J. S., Schiødt, F. V., Ostapowicz, G., Shakil, A. O., et al. (2005) · Hepatology · doi:10.1002/hep.20948 · Cited by 1,913 · see citing works

Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries

Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481 · see citing works

Drug-Related Hepatotoxicity

Navarro, V. J., & Senior, J. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052270 · Cited by 1,076 · see citing works

Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period

Andrade, R. J., Lucena, M. I., Fernández‐Santaella, M. C., Peláez, G. I. C., Pachkoria, K., Garcia-Ruiz, E., García-Muñoz, B., González‐Grande, R., Pizarro, Á., Durán, J. A., et al. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.006 · Cited by 1,041 · see citing works

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

study, F. T. D., Daly, A. K., Donaldson, P. T., Bhatnagar, P., Shen, Y., Pe’er, I., Floratos, A., Daly, M. J., Goldstein, D. B., John, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.379 · Cited by 1,041 · see citing works

Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study

Chalasani, N., Bonkovsky, H. L., Fontana, R., Lee, W., Stolz, A., Talwalkar, J., Reddy, K. R., Watkins, P. B., Navarro, V., Barnhart, H., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.006 · Cited by 925 · see citing works

Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland

Björnsson, E. S., Bergmann, O. M., Björnsson, H. K., Kvaran, R. B., & Olafsson, S. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.006 · Cited by 865 · see citing works

Incidence of drug-induced hepatic injuries: A French population-based study

Sgro, C., Clinard, F., Ouazir, K., Chanay, H., Allard, C., Guilleminet, C., Lenoir, C., Lemoine, A., & Hillon, P. (2002) · Hepatology · doi:10.1053/jhep.2002.34857 · Cited by 843 · see citing works

Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study

Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772 · see citing works

Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease)

DeLeve, L. D., Shulman, H. M., & McDonald, G. B. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-23204 · Cited by 666 · see citing works

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B

McKenzie, R., Fried, M. W., Sallie, R., Conjeevaram, H., Di Bisceglie, A. M., Park, Y., Savarese, B., Kleiner, D., Tsokos, M., Luciano, C., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510263331702 · Cited by 616 · see citing works

Drug-induced liver injury: recent advances in diagnosis and risk assessment

Kullak-Ublick, G. A., Andrade, R. J., Merz, M., End, P., Benesic, A., Gerbes, A. L., & Aithal, G. P. (2017) · Gut · doi:10.1136/gutjnl-2016-313369 · Cited by 492 · see citing works

Drug-Induced Autoimmune Hepatitis: Clinical Characteristics and Prognosis

Bjornsson, E. S., Talwalkar, J. A., Treeprasertsuk, S., Kamath, P. S., Takahashi, N., Sanderson, S. O., Neuhauser, M., & Lindor, K. (2010) · Hepatology · doi:10.1002/hep.23588 · Cited by 487 · see citing works

Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles

Lucena, M. I., Molokhia, M., Shen, Y., Urban, T. J., Aithal, G. P., Andrade, R. J., Day, C. P., Ruiz‐Cabello, F., Donaldson, P. T., Stephens, C. M., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.001 · Cited by 474 · see citing works

Liver injury from herbal and dietary supplements

Navarro, V. J., Khan, I. A., Bjornsson, E. S., Seeff, L. B., Serrano, J., & Hoofnagle, J. H. (2016) · Hepatology · doi:10.1002/hep.28813 · Cited by 462 · see citing works

Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations

Kleiner, D. E., Chalasani, N., Lee, W. M., Fontana, R. J., Bonkovsky, H. L., Watkins, P. B., Hayashi, P. H., Davern, T. J., Navarro, V. J., Reddy, K. R., et al. (2013) · Hepatology · doi:10.1002/hep.26709 · Cited by 424 · see citing works

Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network

Navarro, V. J., Barnhart, H., Bonkovsky, H. L., Davern, T., Fontana, R. J., Grant, L., Reddy, R. K., Seeff, L. B., Serrano, J., Sherker, A. H., et al. (2014) · Hepatology · doi:10.1002/hep.27317 · Cited by 418 · see citing works

Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signals

Lammert, C. S., Einarsson, S., Saha, C., Niklasson, A., Bjornsson, E. S., & Chalasani, N. (2008) · Hepatology · doi:10.1002/hep.22272 · Cited by 389 · see citing works

Hy's law: predicting serious hepatotoxicity

Temple, R. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1211 · Cited by 356 · see citing works

Causality Assessment in Drug-Induced Liver Injury Using A Structured Expert Opinion Process: Comparison to the Roussel-Uclaf Causality Assessment Method

Rockey, D. C., Seeff, L. B., Rochon, J., Freston, J. W., Chalasani, N., Bonacini, M., Fontana, R. J., & Hayashi, P. H. (2010) · Hepatology · doi:10.1002/hep.23577 · Cited by 337 · see citing works

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Richardson, P. G. G., Riches, M., Kernan, N. A., et al. (2016) · Blood · doi:10.1182/blood-2015-10-676924 · Cited by 337 · see citing works

Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports

Bjornsson, E. S., & Hoofnagle, J. H. (2015) · Hepatology · doi:10.1002/hep.28323 · Cited by 257 · see citing works

PTPN22: the archetypal non-HLA autoimmunity gene

Stanford, S. M., & Bottini, N. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.109 · Cited by 245 · see citing works

Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network

Russo, M. W., Hoofnagle, J. H., Gu, J., Fontana, R. J., Barnhart, H. X., Kleiner, D. E., Chalasani, N., & Bonkovsky, H. L. (2014) · Hepatology · doi:10.1002/hep.27157 · Cited by 245 · see citing works

Hepatotoxicity Associated with Supplements Containing Chinese Green Tea (Camellia sinensis)

Bonkovsky, H. L. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-1-200601030-00020 · Cited by 230 · see citing works

Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune‐suppressing and anticancer drugs: Just the tip of the iceberg?

Bisceglie, A. M. D., Lok, A. S.-F., Martin, P. B., et al. (2014) · Hepatology · doi:10.1002/hep.27609 · Cited by 229 · see citing works

Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases

Ghabril, M., Bonkovsky, H. L., Kum, C., Davern, T., Hayashi, P. H., Kleiner, D. E., Serrano, J., Rochon, J., Fontana, R. J., & Bonacini, M. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.025 · Cited by 217 · see citing works

Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury

de Boer, Y. S., Kosinski, A. S., Urban, T. J., Zhao, Z., Long, N., Chalasani, N., Kleiner, D. E., & Hoofnagle, J. H. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.05.043 · Cited by 206 · see citing works

Hepatobiliary Complications of Hematopoietic Cell Transplantation, 40 Years On†

McDonald, G. B. (2010) · Hepatology · doi:10.1002/hep.23533 · Cited by 202 · see citing works

Acute liver failure in Sweden: etiology and outcome

Wei, G., Bergquist, A. M., Broomé, U., Lindgren, S. C., Wallerstedt, S. M., Almer, S. H., Sangfelt, P., Danielsson, A., Sandberg–Gertzén, H., Lööf, L., et al. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01818.x · Cited by 185 · see citing works

Idiosyncratic Liver Injury: Challenges and Approaches

Watkins, P. B. (2005) · Toxicologic Pathology · doi:10.1080/01926230590888306 · Cited by 167 · see citing works

Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements

Bonkovsky, H. L., Kleiner, D. E., Gu, J., et al. (2016) · Hepatology · doi:10.1002/hep.28967 · Cited by 151 · see citing works

Pathologic Changes in Ipilimumab-Related Hepatitis in Patients with Metastatic Melanoma

Kleiner, D. E., & Berman, D. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2140-5 · Cited by 148 · see citing works

Etiology of New-Onset Jaundice: How Often Is It Caused by Idiosyncratic Drug-Induced Liver Injury in The United States?

Vuppalanchi, R., Liangpunsakul, S., & Chalasani, N. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.01019.x · Cited by 146 · see citing works

Amoxicillin–Clavulanate-Induced Liver Injury

Drug-Induced Liver Injury Network (DILIN), deLemos, A. S., Ghabril, M., Rockey, D. C., Gu, J., Barnhart, H. X., Fontana, R. J., Kleiner, D. E., & Bonkovsky, H. L. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4121-6 · Cited by 146 · see citing works

A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury

Cirulli, E. T., Nicoletti, P., Abramson, K., Andrade, R. J., Bjornsson, E. S., Chalasani, N., Fontana, R. J., Hallberg, P., Li, Y., Lucena, M. I., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.034 · Cited by 138 · see citing works

Clinical and Histopathologic Features of Fluoroquinolone-Induced Liver Injury

Orman, E. S., Conjeevaram, H. S., Vuppalanchi, R., Freston, J. W., Rochon, J., Kleiner, D. E., & Hayashi, P. H. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.02.019 · Cited by 134 · see citing works

Clinical and Histologic Features of Azithromycin-Induced Liver Injury

Martínez, M., Vuppalanchi, R., Fontana, R. J., Stolz, A., Kleiner, D. E., Hayashi, P. H., Gu, J., Hoofnagle, J. H., & Chalasani, N. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.054 · Cited by 131 · see citing works

Severe Hypertriglyceridemia With Pancreatitis

Sacks, F. M., Stanesa, M., & Hegele, R. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.13309 · Cited by 119 · see citing works

Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids

Robles‐Díaz, M., Gonzalez-Jimenez, A., Medina‐Cáliz, I., Stephens, C., García‐Cortés, M., García-Muñoz, B., Ortega‐Alonso, A., Blanco‐Reina, E., González‐Grande, R., Pérez, M. J., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13023 · Cited by 119 · see citing works

Case Study: Risperidone-Induced Hepatotoxicity in Pediatric Patients

Kumra, S., Herion, D. W., Jacobsen, L. K., BRIGUGLIA, C., & Grothe, D. R. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199705000-00022 · Cited by 118 · see citing works

Drug-Induced Liver Injury and Drug Development: Industry Perspective

Regev, A. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1375962 · Cited by 110 · see citing works

Hepatotoxicity After Immune Checkpoint Inhibitor Therapy in Melanoma

Huffman, B. M., Kottschade, L. A., Kamath, P. S., & Markovic, S. N. (2017) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000374 · Cited by 108 · see citing works

Characterization of amoxicillin‐ and clavulanic acid‐specific T cells in patients with amoxicillin‐clavulanate–induced liver injury

Kim, S., Saide, K., Farrell, J. J., et al. (2015) · Hepatology · doi:10.1002/hep.27912 · Cited by 98 · see citing works

Hepatotoxicity associated with sustained-release niacin

Dalton, T. A., & Berry, R. S. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90689-9 · Cited by 98 · see citing works

Liver injury from nonsteroidal anti‐inflammatory drugs in the United States

Schmeltzer, P. A., Kosinski, A. S., Kleiner, D. E., Hoofnagle, J. H., Stolz, A., Fontana, R. J., Russo, M. W., & the Drug‐Induced Liver Injury Network (DILIN) (2015) · Liver International · doi:10.1111/liv.13032 · Cited by 96 · see citing works

Genetic Determinants of Drug-induced Cholestasis and Intrahepatic Cholestasis of Pregnancy

Pauli‐Magnus, C., Meier, P. J., & Stieger, B. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1253224 · Cited by 93 · see citing works

The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial

Dostal, A. M., Samavat, H., Bedell, S., Torkelson, C. J., Wang, R., Swenson, K. K., Le, C. T., Wu, A. H., Ursin, G., Yuan, J., et al. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.05.019 · Cited by 88 · see citing works

Drug-Induced liver injury with hypersensitivity features has a better outcome: A single-center experience of 39 children and adolescents

Devarbhavi, H. C., Karanth, D., Prasanna, K. S., Adarsh, C. K., & Patil, M. (2011) · Hepatology · doi:10.1002/hep.24527 · Cited by 84 · see citing works

Tetracycline-induced fatty liver in nonpregnant patients

Peters, R. L., Edmondson, H. A., Mikkelsen, W. P., et al. (1967) · The American Journal of Surgery · doi:10.1016/0002-9610(67)90308-x · Cited by 80 · see citing works

Idiosyncratic Drug Induced Liver Injury in African–Americans Is Associated With Greater Morbidity and Mortality Compared to Caucasians

Chalasani, N., Reddy, R. K. K., Fontana, R. J., Barnhart, H., Gu, J., Hayashi, P. H., Ahmad, J., Stolz, A., Navarro, V., & Hoofnagle, J. H. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.215 · Cited by 75 · see citing works

Azathioprine and 6-Mercaptopurine-induced Liver Injury

Bjornsson, E. S., Gu, J., Kleiner, D. E., Chalasani, N., Hayashi, P. H., & Hoofnagle, J. H. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000568 · Cited by 73 · see citing works

Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors

Stolz, A., Navarro, V. J., Hayashi, P. H., Fontana, R. J., Barnhart, H. X., Gu, J., Chalasani, N., Vega, M., Bonkovsky, H. L., Seeff, L. B., et al. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15211 · Cited by 71 · see citing works

Identification and Characterization of Fenofibrate-Induced Liver Injury

Ahmad, J., Odin, J. A., Hayashi, P. H., Chalasani, N., Fontana, R. J., Barnhart, H. X., Cirulli, E. T., Kleiner, D. E., & Hoofnagle, J. H. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4812-7 · Cited by 70 · see citing works

Drug‐induced liver injury associated with stevens‐Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 cases

Devarbhavi, H. C., Raj, S., Venu, A., Rangegowda, V. T., Veeranna, G. P., Singh, R., Reddy, V., & Patil, M. (2015) · Hepatology · doi:10.1002/hep.28270 · Cited by 67 · see citing works

Identification and Characterization of Cefazolin-Induced Liver Injury

Alqahtani, S. A., Kleiner, D. E., Ghabril, M., Gu, J., Hoofnagle, J. H., & Rockey, D. C. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.11.036 · Cited by 61 · see citing works

The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: A case control study

Cotte, L., Bénet, T., Billioud, C., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.030 · Cited by 54 · see citing works

The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine

Fontana, R. J., Cirulli, E. T., Gu, J., Kleiner, D. E., Ostrov, D. A., Phillips, E. J., Schutte, R. J., Barnhart, H. X., Chalasani, N., Watkins, P. B., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.08.004 · Cited by 53 · see citing works

Anticonvulsant hypersensitivity syndrome: an update

Knowles, S. R., Dewhurst, N., & Shear, N. H. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.705828 · Cited by 51 · see citing works

Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases

Morris‐Stiff, G. J., White, A. D., Gomez, D., et al. (2013) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2013.09.015 · Cited by 45 · see citing works

Linezolid and Lactic Acidosis

Su, E. R., Crowley, K. L., Carcillo, J. A., et al. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182186035 · Cited by 41 · see citing works

Acute hepatitis after parenteral amiodarone administration.

Pye, M. P., Northcote, R. J., & Cobbe, S. M. (1988) · Heart · doi:10.1136/hrt.59.6.690 · Cited by 38 · see citing works

Reye's syndrome developing in an infant on treatment of Kawasaki syndrome

Wei, C., Chen, H., Lee, P., et al. (2005) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2005.00617.x · Cited by 36 · see citing works

Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT

Battipaglia, G., Labopin, M., Candoni, A., Fanin, R., Cheikh, J. E., Blaise, D., Michallet, M., Ruggeri, A., Contentin, N., Ribera, J., et al. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.302 · Cited by 35 · see citing works

DILI and Drug Development: A Regulatory Perspective

Avigan, M. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1375961 · Cited by 34 · see citing works

Clinical and Histological Features of Idiosyncratic Acute Liver Injury Caused by Temozolomide

Grant, L. M., Kleiner, D. E., Conjeevaram, H. S., et al. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2493-9 · Cited by 29 · see citing works

Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients

Nociti, V., Biolato, M., Fino, C. D., et al. (2018) · Brain and Behavior · doi:10.1002/brb3.968 · Cited by 29 · see citing works

Presentation and Outcomes with Clinically Apparent Interferon Beta Hepatotoxicity

Fontana, R. J., Hayashi, P. H., Bonkovsky, H. L., Kleiner, D. E., Kochhar, S., Gu, J., & Ghabril, M. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2553-1 · Cited by 27 · see citing works

Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK® Weight Loss Products: Results from the DILIN Prospective Study

Zheng, E. X., Rossi, S., Fontana, R. J., Vuppalanchi, R., Hoofnagle, J. H., Khan, I. A., & Navarro, V. J. (2016) · Drug Safety · doi:10.1007/s40264-016-0428-7 · Cited by 25 · see citing works

The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients

Dragović, G., & Jevtović, D. (2012) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2011.09.016 · Cited by 24 · see citing works

An Acute Hepatitis Resembling Autoimmune Hepatitis Occurring During Imatinib Therapy in a Gastrointestinal Stromal Tumor Patient

Aliberti, S., Grignani, G., Allione, P., et al. (2009) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31802b4ef7 · Cited by 22 · see citing works

Case Report: Hepatitis C Virus Activation in HIV-Infected Patients Initiating Highly Active Antiretroviral Therapy

Kim, H. N., Harrington, R. D., Shuhart, M. C., et al. (2007) · AIDS Patient Care and STDs · doi:10.1089/apc.2007.0017 · Cited by 9 · see citing works

A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA

Schattenberg, J. M., Pares, A., Kowdley, K. V., Heneghan, M. A., Caldwell, S., Pratt, D., Bonder, A., Hirschfield, G. M., Levy, C., Vierling, J., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.013 · Cited by 191 · see citing works

Management of Acute Liver Failure: Update 2022

Tujios, S., Stravitz, R. T., & Lee, W. M. (2022) · Seminars in Liver Disease · doi:10.1055/s-0042-1755274 · Cited by 117 · see citing works

Human Organoids for Predictive Toxicology Research and Drug Development

Matsui, T., & Shinozawa, T. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.767621 · Cited by 109 · see citing works

Mechanisms of immune checkpoint inhibitor-mediated liver injury

Shojaie, L., Ali, M., Iorga, A., & Dara, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.10.003 · Cited by 98 · see citing works

Immune-mediated drug-induced liver injury: immunogenetics and experimental models

Gerussi, A., Natalini, A., Antonangeli, F., Mancuso, C., Agostinetto, E., Barisani, D., Di Rosa, F., Andrade, R., & Invernizzi, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094557 · Cited by 87 · see citing works

Efferocytosis in liver disease

Shi, H., Moore, M. P., Wang, X., & Tabas, I. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2023.100960 · Cited by 30 · see citing works

Drug‐induced liver injury in Australia, 2009–2020: the increasing proportion of non‐paracetamol cases linked with herbal and dietary supplements

Nash, E., Sabih, A., Chetwood, J., Wood, G., Pandya, K., Yip, T., Majumdar, A., McCaughan, G. W., Strasser, S. I., & Liu, K. (2021) · Medical Journal of Australia · doi:10.5694/mja2.51173 · Cited by 28 · see citing works

Drug induced liver injury is associated with high mortality—A study from a tertiary care hospital in Pakistan

Abid, A., Subhani, F., Kayani, F., Awan, S., & Abid, S. (2020) · PLOS ONE · doi:10.1371/journal.pone.0231398 · Cited by 22 · see citing works

Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase™ from 2010 to 2020

Ortland, I., Mirjalili, M., Kullak-Ublick, G. A., & Peymani, P. (2021) · Swiss Medical Weekly · doi:10.4414/smw.2021.20503 · Cited by 16 · see citing works

Generation of HepG2 Cells with High Expression of Multiple Drug-Metabolizing Enzymes for Drug Discovery Research Using a PITCh System

Negoro, R., Tasaka, M., Deguchi, S., Takayama, K., & Fujita, T. (2022) · Cells · doi:10.3390/cells11101677 · Cited by 16 · see citing works

Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record

Yeboah-Korang, A., Louissaint, J., Tsung, I., Prabhu, S., & Fontana, R. J. (2020) · Drug Safety · doi:10.1007/s40264-019-00903-5 · Cited by 15 · see citing works

N-Acetyltransferase (NAT) 1 and NAT2 Enzyme Activities Drive Interindividual Variability in Sulfamethoxazole N-Acetylation

Lanphier, R. M., Latham, B. D., Gerringer, A. J., Interrante, T., Jones, C. D., De Buysscher, T., Fallon, J. K., & Jackson, K. D. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100195 · Cited by 1 · see citing works

Avoiding drug-induced liver injury

Sweeney, J. (2019) · Pharmacy Today · doi:10.1016/j.ptdy.2019.09.026

Drug-induced Liver Injury:An Analysis of 371 Cases

Weijun, L. (2009) · Zhongguo yiyuan yongyao pingjia yu fenxi

Drug-induced Liver Injury - Tantangan dalamDiagnosis(Drug-induced Liver injury- Diagnostic Challenges)

Loho, I. M., & Hasan, I. (2014)

Drug‐Induced Liver Injury

Sargent, S. (2009) · Wiley eBooks · doi:10.1002/9781444322682.ch15 · Cited by 14 · see citing works

Clinical analysis of 121 cases of drug-induced liver injury by antituberculosis drug

Hu, S. (2010) · Journal of clinical and experimental medicine